Literature DB >> 31477413

The Future of Immunotherapy in the Treatment of Cancer.

Lisa A Kottschade1.   

Abstract

OBJECTIVES: To discuss future direction and present an overview of the evolution of immunotherapy long-term toxicity issues, financial toxicity, and new emerging survivorship considerations. DATA SOURCES: Peer-reviewed manuscripts, Web sites.
CONCLUSION: Cancer treatments involving immunotherapy have had a major impact on long-term survival, toxicity, and survivorship issues. IMPLICATIONS FOR NURSING PRACTICE: Nurses play a pivotal role in the care of the cancer patient across the continuum. With the unique toxicities associated with immunotherapy, it is essential that nurses be keenly aware of all aspects of management, from physical to financial care.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  CAR T-cell therapy; Fertility; Financial toxicity; Immune checkpoint inhibitors; Immune related adverse events; Survivorship; T-VEC

Mesh:

Year:  2019        PMID: 31477413     DOI: 10.1016/j.soncn.2019.08.013

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  5 in total

Review 1.  A Review of Cancer Immunotherapy Toxicity: Immune Checkpoint Inhibitors.

Authors:  Neeraj Chhabra; Joseph Kennedy
Journal:  J Med Toxicol       Date:  2021-04-07

2.  [Clinical Trial Progress and Application of Immune Checkpoint Inhibitors 
in the Treatment of Small Cell Lung Cancer].

Authors:  Huiqiu Zhang; Xiyang Li; Xichuan Li; Yanjun Su
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-11-20

Review 3.  The role of B cells in cancer development.

Authors:  Rongying Tan; Manhua Nie; Wang Long
Journal:  Front Oncol       Date:  2022-08-11       Impact factor: 5.738

4.  Synthesis, Anticancer Activity and Molecular Docking Studies of Novel N-Mannich Bases of 1,3,4-Oxadiazole Based on 4,6-Dimethylpyridine Scaffold.

Authors:  Małgorzata Strzelecka; Teresa Glomb; Małgorzata Drąg-Zalesińska; Julita Kulbacka; Anna Szewczyk; Jolanta Saczko; Paulina Kasperkiewicz-Wasilewska; Nina Rembiałkowska; Kamil Wojtkowiak; Aneta Jezierska; Piotr Świątek
Journal:  Int J Mol Sci       Date:  2022-09-22       Impact factor: 6.208

5.  Integration of tumor inflammation, cell proliferation, and traditional biomarkers improves prediction of immunotherapy resistance and response.

Authors:  Sarabjot Pabla; R J Seager; Erik Van Roey; Shuang Gao; Carrie Hoefer; Mary K Nesline; Paul DePietro; Blake Burgher; Jonathan Andreas; Vincent Giamo; Yirong Wang; Felicia L Lenzo; Margot Schoenborn; Shengle Zhang; Roger Klein; Sean T Glenn; Jeffrey M Conroy
Journal:  Biomark Res       Date:  2021-07-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.